Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSt James's Place Regulatory News (STJ)

Share Price Information for St James's Place (STJ)

Share Price is delayed by 15 minutes
Get Live Data
1,167.00    3.00 (0.26%)
Bid:
1,160.00
Ask:
1,161.00
Spread: 1.00 (0.086%)
Market Cap: £5.94b
STJ Live PriceLast checked at - London Stock Exchange

Intraday St James's Place Share Chart

Director/PDMR Shareholding

30 Dec 2016 10:09

St. James’s Place plc (“SJP”)

SJP was notified on 30 December 2016 of the following changes in SJP shares held by the Executive Director named below.

SJP Performance Share Plan 2005 (“PSP”) and linked Company Share Option Plan 2010 (“CSOP”)

On 21 March 2013, Mr David Bellamy, Executive Director, was awarded a CSOP-linked award, whereby he was granted a nil-cost unapproved option pursuant to the PSP and a linked HMRC approved CSOP option. Mr Bellamy exercised the linked CSOP award on 29 December 2016 with an exercise price of £5.155 per share and, as a result, his linked PSP award automatically lapsed in respect of the number of shares equal in value to the gain realised upon exercise of the linked CSOP award.

Column 1 sets out the number of SJP shares acquired as a result of the exercise of the linked CSOP award on 29 December 2016, and column 2 sets out the number of SJP shares sold on 29 December 2016 at £9.89 per share by Mr Bellamy. Column 3 sets out the number of shares that have lapsed under the linked PSP award as a result of this exercise, and Column 4 sets out the number of PSP award shares retained under the linked PSP award.

1 2 3 4
Name of Director Number of SJP shares acquired on exercise of CSOP option Number of SJP shares sold Number of SJP shares that have lapsed under the linked PSP award Number of SP shares retained under the linked PSP award
David Bellamy 774 407 371 175,807

SJP Performance Share Plan 2005 (“PSP”)

On 21 March 2013 Mr Bellamy was awarded nil cost unapproved PSP awards. On 29 December 2016, Mr Bellamy exercised those awards, as set out in the table below.

Column 1 sets out the number of SJP shares exercised, column 2 sets out the number of SJP shares sold on 29 December 2016 at a price of £9.963 per share by Mr Bellamy in order to settle income tax and National Insurance liabilities. Column 3 sets out the number of SJP shares retained.

1 2 3
Name of Director Number of SJP shares exercised Number of SJP shares sold to meet tax liability Number of SJP shares retained
David Bellamy 175,807 82,837 92,970

Following the above, Mr Bellamy, on 30 December 2016 transferred 80,000 SJP shares by way of gift to members of his family. Mr Bellamy further transferred 13,337 SJP shares by way of gift to the Bellamy Family Trust (“the Trust”) held with the Charities Aid Foundation. Neither Mr Bellamy or a Person Closely Associated with him are Trustees of the Trust and none of the shares held in the Trust are held on his behalf on either a beneficial or non-beneficial basis.

Current Holdings

The table below sets out the current holdings of Mr Bellamy and his Closely Associated Persons* in SJP ordinary shares after the above transactions:

Name of Director Number of SJP shares held
David Bellamy 1,263,080

(i) \* The interests of the Director include those of his Closely Associated Person as defined in Regulation (EU) No 596/2014 (Market Abuse Regulation). The Closely Associated Person of Mr Bellamy is Janette Bellamy.

(ii) The interests of the Director include deferred bonus scheme awards held in trust for the Director which have not yet vested and are subject to forfeiture.

This notification is made in accordance with Article 19(3) of Regulation (EU) No 596/2014 (Market Abuse Regulation).

With the exception of the changes notified in this announcement, the Executive Directors’ shareholdings in SJP are unchanged.

Ann McGookin

Tel: +44 (0)1285 717318

View source version on businesswire.com: http://www.businesswire.com/news/home/20161230005114/en/

Copyright Business Wire 2016

Date   Source Headline
13th Oct 20237:00 amRNSResponse to Media Speculation
2nd Oct 202311:04 amRNSTotal Voting Rights
2nd Oct 20237:00 amRNSDirector/PDMR Shareholding
13th Sep 20237:04 amRNSCEO Succession
1st Sep 20231:10 pmRNSTotal Voting Rights
22nd Aug 20239:43 amRNSHolding(s) in Company
11th Aug 20234:30 pmRNSHolding(s) in Company
1st Aug 202311:40 amRNSBlock listing Interim Review
1st Aug 202310:44 amRNSTotal Voting Rights
27th Jul 20237:00 amRNSHalf-year Report
3rd Jul 20239:58 amRNSTotal Voting Rights
27th Jun 20233:04 pmRNSHolding(s) in Company
2nd Jun 20232:53 pmRNSDirector/PDMR Shareholding
1st Jun 20239:13 amRNSTotal Voting Rights
23rd May 20232:59 pmRNSDirector/PDMR Shareholding
18th May 20231:20 pmRNSResult of AGM
4th May 20232:17 pmRNSDirector/PDMR Shareholding
3rd May 202310:22 amRNSDirector/PDMR Shareholding
2nd May 202311:11 amRNSTotal Voting Rights
27th Apr 20237:00 amRNSQ1 New Business Inflows and Funds Under Management
11th Apr 202311:04 amRNSNotice of AGM
3rd Apr 202311:00 amRNSTotal Voting Rights
31st Mar 20239:57 amRNSDirector/PDMR Shareholding
29th Mar 202312:51 pmRNSDirector/PDMR Shareholding
27th Mar 202311:15 amRNSDirector/PDMR Shareholding
22nd Mar 202311:43 amRNSAdditional Listing
22nd Mar 202311:18 amRNSDirector/PDMR Shareholding
7th Mar 202312:17 pmRNSAnnual Report and Accounts 2022
1st Mar 202311:02 amRNSTotal Voting Rights
28th Feb 20237:00 amRNSFinal Results
1st Feb 202311:50 amRNSTotal Voting Rights
1st Feb 202311:12 amRNSBlock listing Interim Review
26th Jan 20237:00 amRNS2022 New Business Inflows & Funds Under Management
3rd Jan 202312:06 pmRNSTotal Voting Rights
30th Dec 202211:55 amRNSHolding(s) in Company
19th Dec 20224:34 pmRNSHolding(s) in Company
12th Dec 20224:16 pmRNSHolding(s) in Company
1st Dec 202210:21 amRNSTotal Voting Rights
21st Nov 20224:45 pmRNSDirector/PDMR Shareholding
1st Nov 20229:34 amRNSTotal Voting Rights
28th Oct 20221:03 pmRNSDirectorate Change
26th Oct 202211:21 amRNSDirector/PDMR Shareholding
20th Oct 20227:00 amRNSQ3 New Business Inflows and Funds Under Management
19th Oct 20223:56 pmRNSDirector/PDMR Shareholding
17th Oct 20225:02 pmRNSHolding(s) in Company
3rd Oct 202210:20 amRNSTotal Voting Rights
29th Sep 202211:09 amRNSDirector/PDMR Shareholding
15th Sep 20225:10 pmRNSDirector/PDMR Shareholding
1st Sep 20222:08 pmRNSTotal Voting Rights
1st Aug 20223:44 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.